GlassScriptPhysician profile
Atif Iqbal
NPI 1669592473
$15,409.65
in general payments reported to CMS, 2019-2025
20 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,139 · 2020: $760 · 2021: $1,064 · 2022: $7,239 · 2023: $1,843 · 2024: $772 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724 · Travel and Lodging: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,724.16 |
| Travel and Lodging | $483.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,065.79 | 2019-2024 | Da Vinci Surgical System |
| Baxter Healthcare | $2,245.38 | 2019-2020 | |
| Medtronic, INC. | $2,047.21 | 2021-2025 | Signia, Ligasure, Clearify |
| W. L. Gore & Associates, INC. | $1,052.08 | 2019-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Synecor Biomaterial, Seamguard |
| Ethicon US, LLC | $943.43 | 2019-2025 | Echelon Flex, Vistaseal, Harmonic |
| Medical Device Business Services, INC. | $767.54 | 2019-2023 | |
| Covidien LP | $509.41 | 2019-2020 | |
| Integra Lifesciences Corporation | $205.13 | 2020-2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Davol INC. | $111.58 | 2020-2023 | Phasix Mesh |
| Endogastric Solutions, INC | $97.57 | 2020-2023 | Esophyx |
| Intra-Sana Laboratories | $83.05 | 2021 | |
| Medtronic USA, INC. | $74.94 | 2019 | |
| Novo Nordisk INC | $66.02 | 2023-2024 | Wegovy, Saxenda |
| Biom'Up France Sas | $34.72 | 2021 | |
| Lilly USA, LLC | $26.85 | 2024 | Jardiance, Zepbound |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $25.77 | 2024 | Zynrelef |
| Becton, Dickinson and Company | $22.43 | 2025 | Phasix Mesh |
| Tei Biosciences INC | $19.01 | 2019 | |
| Olympus America INC. | $11.74 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atif Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.